300199.SZ
Hybio Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 23.14
−0.26%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- 46.51x
- P/E 2027E
- 33.63x
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 558.88x
- PEG TTM
- —
- Price / book
- 19.08x
- Price / sales
- 20.21x
- Price / cash flow
- 73.16x
Enterprise value
- Enterprise value
- CNY 21.0B
- EV / sales
- 22.00x
- EV / EBITDA
- 101.39x
- EV / EBIT
- 161.71x
- Market cap
- CNY 20.4B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026